Stock Quotes & Company News | Reuters.com
Edition:
United States

People: Abiomed Inc (ABMD.O)

ABMD.O on Nasdaq

110.17USD
1 Jul 2016
Change (% chg)

$0.88 (+0.81%)
Prev Close
$109.29
Open
$109.71
Day's High
$110.20
Day's Low
$108.89
Volume
355,237
Avg. Vol
640,568
52-wk High
$110.68
52-wk Low
$64.03

Rose, Eric 

Dr. Eric A. Rose, M.D., Class II., is an Independent Director of Abiomed Inc.. Dr. Rose has been serving since March 2007 as Executive Vice President for Life Sciences at MacAndrews & Forbes and Chief Executive Officer of Siga Technologies, Inc., a developer of anti-viral drugs directed at potential agents of bioterror. From 1994 to 2007, he was Surgeon in Chief at New York-Presbyterian Hospital/Columbia and Chairman of the Department of Surgery at the Columbia University College of Physicians and Surgeons. A heart surgeon, researcher and entrepreneur, Dr. Rose has helped grow Columbia’s Department of Surgery over the past 25 years while investigating, managing and developing complex medical technologies such as technologies for heart transplantation and new approaches to Alzheimer’s disease and bioterrorism. He has authored or co-authored more than 300 scientific publications and has received more than $25 million in NIH support for his research. Dr. Rose pioneered heart transplantation in children, performing the first pediatric heart transplant in 1984, and has investigated many alternatives to heart transplantation, including cross-species transplantation and man-made heart pumps. He received both his undergraduate and medical degrees from Columbia University.

Basic Compensation

Total Annual Compensation, --
Restricted Stock Awards, --
Long-Term Incentive Plans, --
All Other, --
Fiscal Year Total, --

Options Compensation

  Quantity Market Value
Exercisable -- --
Unexercisable -- --
Exercised -- --
Name Fiscal Year Total

Michael Minogue

5,393,450

Michael Tomsicek

--

David Weber

1,438,480

William Bolt

1,291,870

Andrew Greenfield

536,074

Michael Howley

1,136,130
As Of  30 Mar 2015